Dendritic cell CD83: a therapeutic target or innocent bystander?
about
Functional characterization of the HuR:CD83 mRNA interaction.CD83 increases MHC II and CD86 on dendritic cells by opposing IL-10-driven MARCH1-mediated ubiquitination and degradation.The expression and characterization of functionally active soluble CD83 by Pichia pastoris using high-density fermentation.Targeting membrane proteins for antibody discovery using phage display.Differential effects of estradiol on carotid artery inflammation when administered early versus late after surgical menopause.Thymic CD4 T cell selection requires attenuation of March8-mediated MHCII turnover in cortical epithelial cells through CD83.In vivo confocal microscopy and histopathology of the conjunctiva in trachomatous scarring and normal tissue: a systematic comparison.Soluble CD83 Inhibits T Cell Activation by Binding to the TLR4/MD-2 Complex on CD14+ Monocytes.Dendritic cells and their role in tumor immunosurveillance.Cellular and molecular mechanisms in graft-versus-host disease.The Role of Dendritic Cell Maturation in the Induction of Insulin-Dependent Diabetes Mellitus.Altered heme-mediated modulation of dendritic cell function in sickle cell alloimmunization.Malaria-derived hemozoin exerts early modulatory effects on the phenotype and maturation of human dendritic cells.Imbalanced Macrophage and Dendritic Cell Activations in Response to Candida albicans in a Murine Model of Diabetes Mellitus.Toscana virus infects dendritic and endothelial cells opening the way for the central nervous system.Targeting CD83 for the treatment of graft-versus-host disease.In vitro comparison of commensal, probiotic and pathogenic strains of Enterococcus faecalis.Advance in Targeted Immunotherapy for Graft-Versus-Host Disease.SV-BR-1-GM, a Clinically Effective GM-CSF-Secreting Breast Cancer Cell Line, Expresses an Immune Signature and Directly Activates CD4+ T Lymphocytes.
P2860
Q33988827-E84958DB-387A-4C3C-A09B-A4E7A3A2A009Q34501441-9060E3E4-7A8E-431C-B601-E0D2C5FD76E2Q35106954-D79D4242-5B90-4692-9573-4F9AC8E6DD44Q36020577-2E91E727-950C-4BED-B104-DB9153B1B154Q36124064-EECB0F89-DC80-4936-AD69-6D809FFCD679Q37197974-9E22F390-C9CB-43B6-81C4-3369F81FBF0CQ37206697-2017EB27-5707-4164-91B5-BC35FEF7A80CQ37681536-1CDD61B8-1025-41F6-986D-808C9AF6AAFAQ38021625-C05EAB58-B9E0-4487-9B62-6D4565CC62D7Q38661579-610EC910-96E2-4DC0-AC15-D9E754BFA93BQ39233053-7C8E373D-F9D2-4819-80BA-D4A77B0005C4Q39733403-C1753204-27DD-4B5B-B998-9FEAEB042DF5Q40563795-C8A95160-D0E0-40AC-9E2E-993111919A24Q40703127-265A115A-D1E7-4A7A-91C5-ED50A0730684Q40933810-A9466B42-CBDF-4823-98E7-8F5163EA9E81Q43104684-AD4EAC77-E55A-4947-A40F-FF769403B8E9Q43725901-20EEE690-5D81-45FD-91D0-B40B0AF3B15FQ54937398-789A8F65-9576-4751-A6ED-F01DC803C4DBQ55342016-F99D7BFE-A255-4D67-AE50-6AEBCC90DFF1
P2860
Dendritic cell CD83: a therapeutic target or innocent bystander?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 October 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Dendritic cell CD83: a therapeutic target or innocent bystander?
@en
Dendritic cell CD83: a therapeutic target or innocent bystander?
@nl
type
label
Dendritic cell CD83: a therapeutic target or innocent bystander?
@en
Dendritic cell CD83: a therapeutic target or innocent bystander?
@nl
prefLabel
Dendritic cell CD83: a therapeutic target or innocent bystander?
@en
Dendritic cell CD83: a therapeutic target or innocent bystander?
@nl
P2860
P1433
P1476
Dendritic cell CD83: a therapeutic target or innocent bystander?
@en
P2093
Charlene M Prazma
Thomas F Tedder
P2860
P356
10.1016/J.IMLET.2007.10.001
P577
2007-10-29T00:00:00Z